DDIS-24. DECREASE IN GLIOBLASTOMA GROWTH IN VITRO WITH TREATMENT OF NOVEL ANALOGS OF GLUCOSE TRANSPORTER INHIBITORS

Despite available treatments including surgical resection, radiation and chemotherapy, glioblastoma (GBM) is incurable with rapid recurrence and low median survival rate of just fourteen months. Development of more effective treatments is difficult due to the highly heterogeneous nature of GBM. One...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: GC, Sajina, Libby, Catherine, Zhang, Sixue, Benavides, Gloria, Scott, Sarah, Li, Yanjie, Tran, Anh, Otamias, Arphaxad, Darley-Usmar, Victor, Napierala, Marek, Pathak, Vibha, Moukha-Chafiq, Omar, Augelli-Szafran, Corinne, Zhang, Wei, Hjelmeland, Anita
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Drug Discovery
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847344/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.275
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires